심방세동 절제술 후 폐쇄성 수면 무호흡증 환자에서 CPAP 요법 시작 (STOP-AFib)
방실세동 절제술 후 폐쇄성 수면무호흡증 환자에서 CPAP 요법 시작: 다기관, 개방형, 무작위 임상 시험
Atrial fibrillation (AF) is one of the most common clinical arrhythmias. Catheter ablation is an effective therapeutic strategy; however, recurrence rates remain substantial, ranging from 20% to 45%. Previous studies have established a strong association between obstructive sleep apnea (OSA) and the risk of AF recurrence following ablation. While continuous positive airway pressure (CPAP) is the standard intervention for OSA, and some observational studies suggest it may reduce post-ablation recurrence in patients with comorbid OSA, small randomized controlled trials have failed to confirm a clear benefit, potentially due to poor adherence.
This study aims to evaluate the clinical benefit of post-ablation CPAP therapy in AF patients with comorbid OSA.
Participants will:
- Be randomly assigned to either the CPAP group or the usual care group.
- If in the CPAP group, use a CPAP device for 12 months.
- Wear an ambulatory ECG recorder for a 7-day period at 3, 6, 9, and 12 months after randomization.
- Complete follow-up checkups either at the clinic or over the phone at 1, 3, 6, and 12 months after randomization.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Atrial fibrillation (AF) is a common sustained cardiac arrhythmia, with recurrence rates of 20-45% after catheter ablation. Obstructive sleep apnea (OSA) is a common comorbidity and an important modifiable risk factor for post-ablation AF recurrence. Continuous positive airway pressure (CPAP) is the standard therapy for OSA, but its effect on reducing AF recurrence after ablation remains uncertain.This study aims to evaluate whether, in patients with OSA and AF who undergo catheter ablation, the postoperative CPAP treatment can increase the rate of no recurrence of atrial arrhythmia within one year compared to usual treatment. This prospective, multicenter, open-label, parallel-group randomized controlled trial will be conducted at approximately 20 centers in mainland China. Approximately 658 adults aged 18-75 years with persistent AF and diagnosed OSA who have successfully undergone first-time catheter ablation will be enrolled.
After confirmation of eligibility and informed consent, participants will be randomized in a 1:1 ratio to receive either CPAP therapy plus usual care or usual care alone. CPAP therapy will be provided for 12 months, with treatment parameters determined by pressure titration, and adherence monitored using device-recorded data. Participants in the usual care group will receive standard AF management and standardized education regarding OSA; additional OSA treatments outside the study protocol will be permitted and documented.All participants will receive guideline-directed medical therapy for AF.
Follow-up will last at least 12 months, with assessments at approximately 1, 3, 6, and 12 months after randomization. Atrial arrhythmia monitoring will be performed primarily using ambulatory ECG recorders.
The primary outcome is freedom from atrial arrhythmia recurrence within 12 months after randomization. Secondary outcomes include atrial arrhythmia recurrence patterns, arrhythmia-related interventions, atrial fibrillation burden, and changes in quality-of-life and psychological assessment scores.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Jiang Xie, Professor
- 전화번호: +86 64456360
- 이메일: frank782008@aliyun.com
연구 장소
-
-
-
Tianjin, 중국
- 아직 모집하지 않음
- Tianjin Medical University Second Hospital
-
수석 연구원:
- Xiaoyun Zhao, Professor
-
연락하다:
- Xiaoyun Zhao, Professor
- 전화번호: +86-022-88326681
- 이메일: zxydoctor@163.com
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, 중국, 100029
- 모병
- Beijing Anzhen Hospital
-
연락하다:
- Jiang Xie, Professor
- 전화번호: +86 64456360
- 이메일: frank782008@aliyun.com
-
수석 연구원:
- Jiang Xie, Professor
-
수석 연구원:
- Shaoping Nie, Professor
-
수석 연구원:
- Deyong Long, Professor
-
Beijing, Beijing Municipality, 중국, 100730
- 아직 모집하지 않음
- Beijing Hospital
-
연락하다:
- Wei Gong, Professor
- 전화번호: +86 85132266
- 이메일: gongwei5180@bjhmoh.cn
-
수석 연구원:
- Wei Gong, Professor
-
Beijing, Beijing Municipality, 중국, 102206
- 아직 모집하지 않음
- Peking University International Hospital
-
연락하다:
- Yanwen Jiang, Professor
- 전화번호: +86 01069006163
- 이메일: jiangyanwen@pkuih.edu.cn
-
수석 연구원:
- Yanwen Jiang, Professor
-
Beijing, Beijing Municipality, 중국, 100020
- 아직 모집하지 않음
- Beijing Chaoyang Hospital, Capital Medical University
-
연락하다:
- Zhiling Zhao, Professor
- 전화번호: +86-10-85231000
- 이메일: cysleep@163.com
-
수석 연구원:
- Zhiling Zhao, Professor
-
Beijing, Beijing Municipality, 중국, 100035
- 아직 모집하지 않음
- Beijing Jishuitan Hospital
-
연락하다:
- Yang Cheng, Professor
- 전화번호: +86 01058516688
- 이메일: hengyang0323@outlook.com
-
수석 연구원:
- Yang Cheng, Professor
-
-
Fujian
-
Fuzhou, Fujian, 중국, 350001
- 아직 모집하지 않음
- Fujian Medical University Union Hospital
-
연락하다:
- Xiangqi Chen, Professor
- 전화번호: +86-591-83357896
- 이메일: chxqq2003@126.com
-
수석 연구원:
- Xiangqi Chen, Professor
-
Fuzhou, Fujian, 중국, 350004
- 아직 모집하지 않음
- First Affiliated Hospital of Fujian Medical University
-
연락하다:
- Ningfang Lian, Professor
- 전화번호: +86 059187981698
- 이메일: 1533532863@qq.com
-
수석 연구원:
- Ningfang Lian, Professor
-
Zhangzhou, Fujian, 중국, 363000
- 아직 모집하지 않음
- Zhangzhou Hospital of Fujian Province
-
연락하다:
- Li Lin, Professor
- 전화번호: +86-596-2082000
- 이메일: linlid222@163.com
-
수석 연구원:
- Li Lin, Professor
-
-
Guangxi
-
Nanning, Guangxi, 중국, 530021
- 아직 모집하지 않음
- People's Hospital of Guangxi Zhuang Autonomous Region
-
연락하다:
- Mingming Zhao, Professor
- 전화번호: +86-771-2186076
- 이메일: topabigale@163.com
-
수석 연구원:
- Mingming Zhao, Professor
-
-
Hebei
-
Langfang, Hebei, 중국, 065000
- 아직 모집하지 않음
- Langfang People's Hospital
-
연락하다:
- Zengming Xue, Professor
- 전화번호: +86 03162369665
- 이메일: xuezengming@163.com
-
수석 연구원:
- Zengming Xue, Professor
-
Shijiazhuang, Hebei, 중국, 050000
- 모병
- Shijiazhuang Great Wall Hospital of Integrated Traditional Chinese and Western Medicine
-
연락하다:
- Linyi Huang, Professor
- 전화번호: +86-0311-85837801
- 이메일: 496777551@qq.com
-
수석 연구원:
- Linyi Huang, Professor
-
Xingtai, Hebei, 중국, 055250
- 모병
- The Ninth Hospital of Xingtai
-
연락하다:
- Zhanwei Liu, Professor
- 전화번호: +86-0319-4321827
- 이메일: liuzhanweidf@sina.com
-
수석 연구원:
- Zhanwei Liu, Professor
-
-
Heilongjiang
-
Harbin, Heilongjiang, 중국, 150086
- 아직 모집하지 않음
- Second Affiliated Hospital of Harbin Medical University
-
연락하다:
- Wei Meng, Professor
- 전화번호: +86 045186296870
- 이메일: mengweixq@163.com
-
수석 연구원:
- Wei Meng, Professor
-
-
Henan
-
Shangqiu, Henan, 중국
- 아직 모집하지 않음
- Shangqiu First People's Hospital
-
연락하다:
- Renshan Niu, Professor
- 전화번호: +86-0370-3255630
- 이메일: niurenshan1965@163.com
-
수석 연구원:
- Renshan Niu, Professor
-
Zhengzhou, Henan, 중국, 450052
- 아직 모집하지 않음
- The First Affiliated Hospital of Zhengzhou University
-
연락하다:
- Gangqiong Liu
- 전화번호: +86-371-66913114
- 이메일: doctorliu61352@163.com
-
수석 연구원:
- Gangqiong Liu, Professor
-
-
Hubei
-
Wuhan, Hubei, 중국, 430014
- 아직 모집하지 않음
- Wuhan No. 1 Hospital
-
연락하다:
- Zhihua Yu, Professor
- 전화번호: +86 02785332144
- 이메일: whyu027@163.com
-
수석 연구원:
- Zhihua Yu, Professor
-
Wuhan, Hubei, 중국, 430056
- 아직 모집하지 않음
- Wuhan Asia General Hospital
-
연락하다:
- Ning Man, Professor
- 전화번호: +86-027-84788999
- 이메일: Mannyl75@126.com
-
수석 연구원:
- Ning Man, Professor
-
-
Hunan
-
Changsha, Hunan, 중국, 410011
- 아직 모집하지 않음
- The Second Xiangya Hospital of Central South University
-
연락하다:
- Ruoyun Ouyang, Professor
- 전화번호: +86-731-85295888
- 이메일: ouyangruoyun@csu.edu.cn
-
수석 연구원:
- Ruoyun Ouyang, Professor
-
-
Jiangsu
-
Nanjing, Jiangsu, 중국, 210029
- 아직 모집하지 않음
- The First Affiliated Hospital of Nanjing Medical University
-
연락하다:
- Ning Ding, Professor
- 전화번호: +86 02568307346
- 이메일: dingning@njmu.edu.cn
-
수석 연구원:
- Ning Ding, Professor
-
-
Jilin
-
Changchun, Jilin, 중국, 130021
- 아직 모집하지 않음
- The First Hospital of Jilin University
-
연락하다:
- Haibo Yuan, Professor
- 전화번호: +86-431-88782222
- 이메일: hyuan@jlu.edu.cn
-
수석 연구원:
- Haibo Yuan, Professor
-
-
Liaoning
-
Dalian, Liaoning, 중국, 116011
- 아직 모집하지 않음
- First Affiliated Hospital of Dalian Medical University
-
연락하다:
- Haiying Tang, Professor
- 전화번호: +86 0411836359632561
- 이메일: doctortanghy@163.com
-
수석 연구원:
- Haiying Tang, Professor
-
Shenyang, Liaoning, 중국, 110004
- 아직 모집하지 않음
- Shengjing Hospital of China Medical University
-
연락하다:
- Li Xiao, Professor
- 전화번호: +86-24-96615
- 이메일: xiaolisy@163.com
-
수석 연구원:
- Li Xiao, Professor
-
Shenyang, Liaoning, 중국, 110001
- 아직 모집하지 않음
- First Affiliated Hospital of China Medical University
-
연락하다:
- Wenyang Li, Professor
- 전화번호: +86 83282530
- 이메일: 20122043@cmu.edu.cn
-
수석 연구원:
- Wenyang Li, Professor
-
-
Shandong
-
Dongying, Shandong, 중국, 257034
- 아직 모집하지 않음
- Shengli Oilfield Central Hospital
-
연락하다:
- Xiangfei Liu, Professor
- 전화번호: +86-546-8551222
- 이메일: zhaoyang20023903@126.com
-
수석 연구원:
- Xiangfei Liu, Professor
-
Linyi, Shandong, 중국, 276003
- 아직 모집하지 않음
- Linyi People's Hospital
-
연락하다:
- Li Wei, Professor
- 전화번호: +86-539-8216261
- 이메일: weilineu@163.com
-
수석 연구원:
- Li Wei, Professor
-
-
Shanxi
-
Taiyuan, Shanxi, 중국, 030001
- 아직 모집하지 않음
- Second Hospital of Shanxi Medical University
-
연락하다:
- Xiaoling Gao, Professor
- 전화번호: +86 03513362858
- 이메일: yihexiyuan@qq.com
-
수석 연구원:
- Xiaoling Gao, Professor
-
-
Tianjin Municipality
-
Tianjin, Tianjin Municipality, 중국, 300222
- 아직 모집하지 않음
- Tianjin Chest Hospital
-
연락하다:
- Fang Zhao, Professor
- 전화번호: +86-22-88185111
- 이메일: zfangdoctortjxkyy@163.com
-
수석 연구원:
- Fang Zhao, Professor
-
-
Yunnan
-
Kunming, Yunnan, 중국
- 아직 모집하지 않음
- Yan'an Hospital of Kunming City
-
연락하다:
- Xia Jiang, Professor
- 전화번호: +86-0871-63211073
- 이메일: 378972370@qq.com
-
수석 연구원:
- Xia Jiang, Professor
-
-
Zhejiang
-
Ningbo, Zhejiang, 중국, 315010
- 아직 모집하지 않음
- First Affiliated Hospital of Ningbo University
-
연락하다:
- Maoqing Tong, Professor
- 전화번호: +86 57487085588
- 이메일: ganbaursy@163.com
-
수석 연구원:
- Maoqing Tong, Professor
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Patients must meet all of the following conditions to be eligible for the study:
- Age 18-75 years.
- Patients with persistent AF who received catheter ablation for the first time.
- Diagnosed with OSA.
- Able to tolerate CPAP therapy.
- Capable of understanding and complying with the study protocol.
- Willing to sign the informed consent form.
Exclusion Criteria:
Patients meeting any of the following criteria will be excluded from the study:
- Secondary AF.
- Left atrial anteroposterior diameter 60mm (measured via parasternal long-axis view).
- Left ventricular ejection fraction < 30%.
- Comorbid moderate-to-severe mitral stenosis or history of prosthetic valve replacement (mechanical or bioprosthetic).
- Pregnant or breastfeeding women.
- History of myocardial infarction, percutaneous coronary intervention, or cardiac surgery within 3 months prior to screening.
- History of stroke or transient ischemic attack within 6 months prior to screening.
- Perioperative complications related to the ablation procedure occurring prior to randomization.
- Inability to discontinue antiarrhythmic drugs (AADs) post-procedure due to other reasons.
- Life expectancy < 1 year.
- Central sleep apnea.
- Conditions requiring ventilatory support, including obesity hypoventilation syndrome (defined as BMI > 30kg/m² and awake PaCO₂ > 45mmHg), amyotrophic lateral sclerosis, or chronic obstructive pulmonary disease with > 1 episode of respiratory failure or hypercapnia.
- Treatment-emergent central sleep apnea during CPAP tolerance assessment that cannot be corrected prior to randomization.
- Receipt of instrumental or surgical treatment for OSA within 3 months prior to screening, including CPAP, oral appliances, ENT surgery, or bariatric surgery.
- Use of glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide receptor agonists, or glucagon receptor agonists for weight loss within 3 months prior to screening, or plans to initiate such medications within the next year.
- Current participation in other drug or device trials.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: CPAP Group
Usual care combined with CPAP therapy. |
Participants receive CPAP therapy provided by the research team. Treatment parameters are determined following auto-titrating or manual pressure titration. Prior to treatment initiation, participants receive training on device usage, mask fitting and adjustment, equipment cleaning and maintenance, and data transmission methods. Study physicians and technicians provide support to address any CPAP-related discomfort. 'Good adherence' is defined as device usage of ≥ 4 hours per night on ≥ 70% of days. Participants receive standardized medical therapy for atrial fibrillation in accordance with international guidelines and clinical routine. For OSA management, researchers provide standardized health education. This includes informing participants about the risks associated with OSA and advising on lifestyle modifications, including weight loss, adopting a lateral sleeping position, and avoiding alcohol and sedatives. |
|
활성 비교기: Usual Care Group
Standard of care for atrial fibrillation and usual care for OSA (health education). Researchers advise participants to visit sleep centers or pulmonology departments for further assessment/treatment at their own discretion, but do not intervene in their choice of OSA therapy or provide the study CPAP device. |
Participants receive standardized medical therapy for atrial fibrillation in accordance with international guidelines and clinical routine. For OSA management, researchers provide standardized health education. This includes informing participants about the risks associated with OSA and advising on lifestyle modifications, including weight loss, adopting a lateral sleeping position, and avoiding alcohol and sedatives. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Incidence of freedom from atrial arrhythmia recurrence.
기간: Within 12 months
|
Recurrence is defined as a composite of:
|
Within 12 months
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
문서화된 심방성 부정맥(AF/AFL/AT)의 발생률(지속 시간 ≥30초).
기간: 12개월 이내 (3개월 공백 기간 후).
|
12개월 이내 (3개월 공백 기간 후).
|
|
|
30초 이상 지속된 문서화된 심방세동의 발생률.
기간: 12개월 이내 (3개월 공백 기간 후).
|
12개월 이내 (3개월 공백 기간 후).
|
|
|
문서화된 AT 발생률 (30초 이상 지속된 경우).
기간: 12개월 이내(3개월 공백 기간 후).
|
12개월 이내(3개월 공백 기간 후).
|
|
|
30초 이상 지속된 문서화된 심방조동의 발생률.
기간: 12개월 이내(3개월의 무효 기간 이후).
|
12개월 이내(3개월의 무효 기간 이후).
|
|
|
클래스 I 또는 III 항부정맥제를 사용하는 환자의 비율.
기간: 3개월 공백 기간 후 12개월 이내.
|
3개월 공백 기간 후 12개월 이내.
|
|
|
심율동 전환을 받는 환자의 비율.
기간: 12개월 이내(3개월 공백 기간 후).
|
12개월 이내(3개월 공백 기간 후).
|
|
|
반복 카테터 절제술을 받는 환자의 비율.
기간: 12개월 이내.
|
12개월 이내.
|
|
|
AF 부담
기간: 12개월 이내에.
|
12개월 이내에.
|
|
|
Change in quality of life assessed by the Atrial Fibrillation Effect on Quality-of-Life questionnaire.
기간: Baseline, Month 12.
|
Scores range from 0 to 100, where higher scores indicate a better quality of life. |
Baseline, Month 12.
|
|
Change in anxiety and depression assessed by the Hospital Anxiety and Depression Scale.
기간: Baseline, Month 12.
|
Scores for both the anxiety and depression subscales range from 0 to 21, where higher scores indicate worse anxiety and depression. |
Baseline, Month 12.
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Caples SM, Mansukhani MP, Friedman PA, Somers VK. The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: A randomized controlled trial. Int J Cardiol. 2019 Mar 1;278:133-136. doi: 10.1016/j.ijcard.2018.11.100. Epub 2018 Nov 20.
- Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, Mehra R, Bozkurt B, Ndumele CE, Somers VK. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021 Jul 20;144(3):e56-e67. doi: 10.1161/CIR.0000000000000988. Epub 2021 Jun 21.
- Dretzke J, Chuchu N, Agarwal R, Herd C, Chua W, Fabritz L, Bayliss S, Kotecha D, Deeks JJ, Kirchhof P, Takwoingi Y. Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models. Europace. 2020 May 1;22(5):748-760. doi: 10.1093/europace/euaa041.
- Sanchez-de-la-Torre M, Gracia-Lavedan E, Benitez ID, Sanchez-de-la-Torre A, Moncusi-Moix A, Torres G, Loffler K, Woodman R, Adams R, Labarca G, Dreyse J, Eulenburg C, Thunstrom E, Glantz H, Peker Y, Anderson C, McEvoy D, Barbe F. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. JAMA. 2023 Oct 3;330(13):1255-1265. doi: 10.1001/jama.2023.17465.
- Hunt TE, Traaen GM, Aakeroy L, Bendz C, Overland B, Akre H, Steinshamn S, Loennechen JP, Hegbom F, Broch K, Lie OH, Lyseggen E, Haugaa KH, Gullestad L, Anfinsen OG. Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial. Heart Rhythm. 2022 Sep;19(9):1433-1441. doi: 10.1016/j.hrthm.2022.06.016. Epub 2022 Jun 16.
- Zhou Y, Yan M, Yuan J, Wang Y, Qiao S. Continuous Positive Airway Pressure Treatment Decreases the Risk of Atrial Fibrillation Recurrence in Patients with Obstructive Sleep Apnea after Radiofrequency Ablation. Int Heart J. 2022 Jul 30;63(4):716-721. doi: 10.1536/ihj.22-129. Epub 2022 Jul 14.
- Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, Hylek EM, Mahaffey KW, Freeman JV, Chang P, Holmes DN, Peterson ED, Piccini JP, Gersh BJ; ORBIT-AF Investigators. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015 May;169(5):647-654.e2. doi: 10.1016/j.ahj.2014.12.024. Epub 2015 Feb 7.
- Deng F, Raza A, Guo J. Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis. Sleep Med. 2018 Jun;46:5-11. doi: 10.1016/j.sleep.2018.02.013. Epub 2018 Mar 22.
- de Heide J, Kock-Cordeiro DBM, Bhagwandien RE, Hoogendijk MG, van der Meer KC, Wijchers SA, Szili-Torok T, Zijlstra F, Lenzen MJ, Yap SC. Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation (OSA-AF study). Int J Cardiol Heart Vasc. 2022 Mar 24;40:101014. doi: 10.1016/j.ijcha.2022.101014. eCollection 2022 Jun.
- Minami T, Yoshizawa T, Murase K, Komasa A, Aizawa T, Yamagami S, Tanaka M, Shizuta S, Sato S, Ono K, Hirai T, Kimura T, Chin K. Associations Among Sleep Apnea, Objective or Subjective Sleep Duration, and Recurrence of Atrial Fibrillation in Patients Who Undergo Radiofrequency Catheter Ablation for Persistent Atrial Fibrillation - A Prospective Observational Study. Circ J. 2025 Jan 24;89(2):184-194. doi: 10.1253/circj.CJ-24-0537. Epub 2024 Nov 12.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- KS2025046
- 2024ZD0529100 (기타 보조금/기금 번호: Development Center for Medical Science & Technology National Health Commission of the People's Republic of China)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .